Standard BioTools Inc.
Standard BioTools Inc. FLDM Peers
See (FLDM) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| FLDM | $3.71 | -7.02% | 294.2M | -4.74 | -$0.78 | N/A |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.58% |
| TMO | $403.62 | +0.92% | 152.4B | 23.69 | $17.04 | +0.40% |
| DHR | $193.08 | +0.53% | 138.2B | 37.35 | $5.17 | +0.58% |
| IDXX | $524.78 | -0.20% | 42.2B | 48.46 | $10.83 | N/A |
| A | $114.98 | +1.97% | 32.8B | 28.32 | $4.06 | +0.84% |
| IQV | $147.87 | +3.56% | 25.6B | 20.17 | $7.33 | N/A |
| MTD | $1,169.77 | +0.28% | 24.3B | 29.24 | $40.01 | N/A |
| NTRA | $167.32 | +4.48% | 22.8B | -113.82 | -$1.47 | N/A |
| WAT | $353.03 | +1.04% | 21B | 32.01 | $11.03 | N/A |
Stock Comparison
FLDM vs DHR-PB Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, FLDM is priced at $3.71, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, FLDM's ROE is -0.28%, compared to DHR-PB's ROE of +0.07%. Regarding short-term risk, FLDM is more volatile compared to DHR-PB. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs TMO Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, TMO has a market cap of 152.4B. Regarding current trading prices, FLDM is priced at $3.71, while TMO trades at $403.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas TMO's P/E ratio is 23.69. In terms of profitability, FLDM's ROE is -0.28%, compared to TMO's ROE of +0.13%. Regarding short-term risk, FLDM is more volatile compared to TMO. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs DHR Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, DHR has a market cap of 138.2B. Regarding current trading prices, FLDM is priced at $3.71, while DHR trades at $193.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas DHR's P/E ratio is 37.35. In terms of profitability, FLDM's ROE is -0.28%, compared to DHR's ROE of +0.07%. Regarding short-term risk, FLDM is more volatile compared to DHR. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs IDXX Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, IDXX has a market cap of 42.2B. Regarding current trading prices, FLDM is priced at $3.71, while IDXX trades at $524.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas IDXX's P/E ratio is 48.46. In terms of profitability, FLDM's ROE is -0.28%, compared to IDXX's ROE of +0.57%. Regarding short-term risk, FLDM is more volatile compared to IDXX. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs A Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, A has a market cap of 32.8B. Regarding current trading prices, FLDM is priced at $3.71, while A trades at $114.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas A's P/E ratio is 28.32. In terms of profitability, FLDM's ROE is -0.28%, compared to A's ROE of +0.19%. Regarding short-term risk, FLDM is more volatile compared to A. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs IQV Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, IQV has a market cap of 25.6B. Regarding current trading prices, FLDM is priced at $3.71, while IQV trades at $147.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas IQV's P/E ratio is 20.17. In terms of profitability, FLDM's ROE is -0.28%, compared to IQV's ROE of +0.21%. Regarding short-term risk, FLDM is more volatile compared to IQV. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs MTD Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, MTD has a market cap of 24.3B. Regarding current trading prices, FLDM is priced at $3.71, while MTD trades at $1,169.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas MTD's P/E ratio is 29.24. In terms of profitability, FLDM's ROE is -0.28%, compared to MTD's ROE of +1.21%. Regarding short-term risk, FLDM is more volatile compared to MTD. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs NTRA Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, NTRA has a market cap of 22.8B. Regarding current trading prices, FLDM is priced at $3.71, while NTRA trades at $167.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas NTRA's P/E ratio is -113.82. In terms of profitability, FLDM's ROE is -0.28%, compared to NTRA's ROE of -0.18%. Regarding short-term risk, FLDM is more volatile compared to NTRA. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs WAT Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, WAT has a market cap of 21B. Regarding current trading prices, FLDM is priced at $3.71, while WAT trades at $353.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas WAT's P/E ratio is 32.01. In terms of profitability, FLDM's ROE is -0.28%, compared to WAT's ROE of +0.39%. Regarding short-term risk, FLDM is more volatile compared to WAT. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs DGX Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, DGX has a market cap of 19.4B. Regarding current trading prices, FLDM is priced at $3.71, while DGX trades at $173.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas DGX's P/E ratio is 21.95. In terms of profitability, FLDM's ROE is -0.28%, compared to DGX's ROE of +0.13%. Regarding short-term risk, FLDM is more volatile compared to DGX. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs PKI Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, FLDM is priced at $3.71, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas PKI's P/E ratio is 41.45. In terms of profitability, FLDM's ROE is -0.28%, compared to PKI's ROE of +0.04%. Regarding short-term risk, FLDM is more volatile compared to PKI. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs ILMN Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, ILMN has a market cap of 13.2B. Regarding current trading prices, FLDM is priced at $3.71, while ILMN trades at $83.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas ILMN's P/E ratio is -13.68. In terms of profitability, FLDM's ROE is -0.28%, compared to ILMN's ROE of -0.46%. Regarding short-term risk, FLDM is more volatile compared to ILMN. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs ICLR Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, ICLR has a market cap of 11.3B. Regarding current trading prices, FLDM is priced at $3.71, while ICLR trades at $139.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas ICLR's P/E ratio is 15.21. In terms of profitability, FLDM's ROE is -0.28%, compared to ICLR's ROE of +0.08%. Regarding short-term risk, FLDM is more volatile compared to ICLR. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs RVTY Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, RVTY has a market cap of 10.9B. Regarding current trading prices, FLDM is priced at $3.71, while RVTY trades at $92.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas RVTY's P/E ratio is 38.17. In terms of profitability, FLDM's ROE is -0.28%, compared to RVTY's ROE of +0.04%. Regarding short-term risk, FLDM is more volatile compared to RVTY. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs TEM Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, TEM has a market cap of 10.6B. Regarding current trading prices, FLDM is priced at $3.71, while TEM trades at $62.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas TEM's P/E ratio is -12.17. In terms of profitability, FLDM's ROE is -0.28%, compared to TEM's ROE of -5.31%. Regarding short-term risk, FLDM is more volatile compared to TEM. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs EXAS Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, EXAS has a market cap of 10.4B. Regarding current trading prices, FLDM is priced at $3.71, while EXAS trades at $55.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas EXAS's P/E ratio is -9.97. In terms of profitability, FLDM's ROE is -0.28%, compared to EXAS's ROE of -0.36%. Regarding short-term risk, FLDM is more volatile compared to EXAS. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs QGEN Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, QGEN has a market cap of 9.9B. Regarding current trading prices, FLDM is priced at $3.71, while QGEN trades at $45.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas QGEN's P/E ratio is 106.33. In terms of profitability, FLDM's ROE is -0.28%, compared to QGEN's ROE of +0.03%. Regarding short-term risk, FLDM is more volatile compared to QGEN. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs MEDP Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, MEDP has a market cap of 9B. Regarding current trading prices, FLDM is priced at $3.71, while MEDP trades at $312.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas MEDP's P/E ratio is 23.86. In terms of profitability, FLDM's ROE is -0.28%, compared to MEDP's ROE of +0.54%. Regarding short-term risk, FLDM is more volatile compared to MEDP. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs CRL Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, CRL has a market cap of 7B. Regarding current trading prices, FLDM is priced at $3.71, while CRL trades at $143.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas CRL's P/E ratio is -234.80. In terms of profitability, FLDM's ROE is -0.28%, compared to CRL's ROE of -0.01%. Regarding short-term risk, FLDM is more volatile compared to CRL. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs GH Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, GH has a market cap of 5.9B. Regarding current trading prices, FLDM is priced at $3.71, while GH trades at $47.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas GH's P/E ratio is -14.09. In terms of profitability, FLDM's ROE is -0.28%, compared to GH's ROE of +3.69%. Regarding short-term risk, FLDM is more volatile compared to GH. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs SYNH Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, FLDM is priced at $3.71, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas SYNH's P/E ratio is 61.40. In terms of profitability, FLDM's ROE is -0.28%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, FLDM is more volatile compared to SYNH. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs RDNT Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, RDNT has a market cap of 4.3B. Regarding current trading prices, FLDM is priced at $3.71, while RDNT trades at $56.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas RDNT's P/E ratio is -132.09. In terms of profitability, FLDM's ROE is -0.28%, compared to RDNT's ROE of +0.03%. Regarding short-term risk, FLDM is more volatile compared to RDNT. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs SHC Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, SHC has a market cap of 3.5B. Regarding current trading prices, FLDM is priced at $3.71, while SHC trades at $12.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas SHC's P/E ratio is 137.33. In terms of profitability, FLDM's ROE is -0.28%, compared to SHC's ROE of +0.06%. Regarding short-term risk, FLDM is more volatile compared to SHC. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs OLK Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, FLDM is priced at $3.71, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas OLK's P/E ratio is -96.59. In terms of profitability, FLDM's ROE is -0.28%, compared to OLK's ROE of -0.05%. Regarding short-term risk, FLDM is more volatile compared to OLK. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs TWST Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, TWST has a market cap of 1.8B. Regarding current trading prices, FLDM is priced at $3.71, while TWST trades at $30.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas TWST's P/E ratio is -9.37. In terms of profitability, FLDM's ROE is -0.28%, compared to TWST's ROE of -0.41%. Regarding short-term risk, FLDM is more volatile compared to TWST. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs VIVO Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, VIVO has a market cap of 1.5B. Regarding current trading prices, FLDM is priced at $3.71, while VIVO trades at $33.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas VIVO's P/E ratio is 21.09. In terms of profitability, FLDM's ROE is -0.28%, compared to VIVO's ROE of +0.12%. Regarding short-term risk, FLDM is more volatile compared to VIVO. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs GRAL Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, GRAL has a market cap of 1.4B. Regarding current trading prices, FLDM is priced at $3.71, while GRAL trades at $40.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas GRAL's P/E ratio is -0.67. In terms of profitability, FLDM's ROE is -0.28%, compared to GRAL's ROE of -0.75%. Regarding short-term risk, FLDM is more volatile compared to GRAL. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs NEOG Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, NEOG has a market cap of 1.1B. Regarding current trading prices, FLDM is priced at $3.71, while NEOG trades at $4.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas NEOG's P/E ratio is -2.22. In terms of profitability, FLDM's ROE is -0.28%, compared to NEOG's ROE of -0.17%. Regarding short-term risk, FLDM is less volatile compared to NEOG. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs CDNA Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, CDNA has a market cap of 1.1B. Regarding current trading prices, FLDM is priced at $3.71, while CDNA trades at $19.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas CDNA's P/E ratio is 17.23. In terms of profitability, FLDM's ROE is -0.28%, compared to CDNA's ROE of +0.18%. Regarding short-term risk, FLDM is more volatile compared to CDNA. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs OPK Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, OPK has a market cap of 1.1B. Regarding current trading prices, FLDM is priced at $3.71, while OPK trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas OPK's P/E ratio is -22.42. In terms of profitability, FLDM's ROE is -0.28%, compared to OPK's ROE of -0.03%. Regarding short-term risk, FLDM is more volatile compared to OPK. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs FLGT Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, FLGT has a market cap of 648.1M. Regarding current trading prices, FLDM is priced at $3.71, while FLGT trades at $21.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas FLGT's P/E ratio is -16.01. In terms of profitability, FLDM's ROE is -0.28%, compared to FLGT's ROE of -0.04%. Regarding short-term risk, FLDM is more volatile compared to FLGT. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs GRALV Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, FLDM is priced at $3.71, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas GRALV's P/E ratio is N/A. In terms of profitability, FLDM's ROE is -0.28%, compared to GRALV's ROE of N/A. Regarding short-term risk, FLDM is more volatile compared to GRALV. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs CSTL Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, CSTL has a market cap of 490.8M. Regarding current trading prices, FLDM is priced at $3.71, while CSTL trades at $17.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas CSTL's P/E ratio is -89.47. In terms of profitability, FLDM's ROE is -0.28%, compared to CSTL's ROE of -0.01%. Regarding short-term risk, FLDM is more volatile compared to CSTL. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs MYGN Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, MYGN has a market cap of 487.6M. Regarding current trading prices, FLDM is priced at $3.71, while MYGN trades at $5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas MYGN's P/E ratio is -4.72. In terms of profitability, FLDM's ROE is -0.28%, compared to MYGN's ROE of -0.15%. Regarding short-term risk, FLDM is less volatile compared to MYGN. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs PSNL Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, PSNL has a market cap of 456.2M. Regarding current trading prices, FLDM is priced at $3.71, while PSNL trades at $5.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas PSNL's P/E ratio is -4.00. In terms of profitability, FLDM's ROE is -0.28%, compared to PSNL's ROE of -0.49%. Regarding short-term risk, FLDM is more volatile compared to PSNL. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs LAB Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, LAB has a market cap of 410.2M. Regarding current trading prices, FLDM is priced at $3.71, while LAB trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas LAB's P/E ratio is -3.37. In terms of profitability, FLDM's ROE is -0.28%, compared to LAB's ROE of -0.28%. Regarding short-term risk, FLDM is more volatile compared to LAB. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs CO Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, FLDM is priced at $3.71, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas CO's P/E ratio is 5.06. In terms of profitability, FLDM's ROE is -0.28%, compared to CO's ROE of +0.11%. Regarding short-term risk, FLDM is less volatile compared to CO. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs STIM Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, STIM has a market cap of 255.4M. Regarding current trading prices, FLDM is priced at $3.71, while STIM trades at $3.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas STIM's P/E ratio is -2.94. In terms of profitability, FLDM's ROE is -0.28%, compared to STIM's ROE of -2.09%. Regarding short-term risk, FLDM is more volatile compared to STIM. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs NEO Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, NEO has a market cap of 190M. Regarding current trading prices, FLDM is priced at $3.71, while NEO trades at $7.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas NEO's P/E ratio is -12.10. In terms of profitability, FLDM's ROE is -0.28%, compared to NEO's ROE of -0.09%. Regarding short-term risk, FLDM is more volatile compared to NEO. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs ACRS Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, ACRS has a market cap of 173.2M. Regarding current trading prices, FLDM is priced at $3.71, while ACRS trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas ACRS's P/E ratio is -1.01. In terms of profitability, FLDM's ROE is -0.28%, compared to ACRS's ROE of -0.92%. Regarding short-term risk, FLDM is less volatile compared to ACRS. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs XGN Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, XGN has a market cap of 161.1M. Regarding current trading prices, FLDM is priced at $3.71, while XGN trades at $7.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas XGN's P/E ratio is -8.77. In terms of profitability, FLDM's ROE is -0.28%, compared to XGN's ROE of -1.34%. Regarding short-term risk, FLDM is more volatile compared to XGN. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs ATLN Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, ATLN has a market cap of 129.6M. Regarding current trading prices, FLDM is priced at $3.71, while ATLN trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas ATLN's P/E ratio is -0.60. In terms of profitability, FLDM's ROE is -0.28%, compared to ATLN's ROE of -19.68%. Regarding short-term risk, FLDM is less volatile compared to ATLN. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs GTH Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, FLDM is priced at $3.71, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas GTH's P/E ratio is -1.11. In terms of profitability, FLDM's ROE is -0.28%, compared to GTH's ROE of -1.01%. Regarding short-term risk, FLDM is more volatile compared to GTH. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs PRE Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, PRE has a market cap of 117.6M. Regarding current trading prices, FLDM is priced at $3.71, while PRE trades at $9.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas PRE's P/E ratio is -2.43. In terms of profitability, FLDM's ROE is -0.28%, compared to PRE's ROE of -0.25%. Regarding short-term risk, FLDM is less volatile compared to PRE. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs GENE Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, FLDM is priced at $3.71, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas GENE's P/E ratio is -38.25. In terms of profitability, FLDM's ROE is -0.28%, compared to GENE's ROE of -3.62%. Regarding short-term risk, FLDM is more volatile compared to GENE. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs MDXH Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, MDXH has a market cap of 105.9M. Regarding current trading prices, FLDM is priced at $3.71, while MDXH trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas MDXH's P/E ratio is -2.06. In terms of profitability, FLDM's ROE is -0.28%, compared to MDXH's ROE of -6.91%. Regarding short-term risk, FLDM is more volatile compared to MDXH. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs NOTV Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, NOTV has a market cap of 102.9M. Regarding current trading prices, FLDM is priced at $3.71, while NOTV trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas NOTV's P/E ratio is -0.96. In terms of profitability, FLDM's ROE is -0.28%, compared to NOTV's ROE of -0.51%. Regarding short-term risk, FLDM is less volatile compared to NOTV. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs PRENW Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, PRENW has a market cap of 93.7M. Regarding current trading prices, FLDM is priced at $3.71, while PRENW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas PRENW's P/E ratio is N/A. In terms of profitability, FLDM's ROE is -0.28%, compared to PRENW's ROE of -0.25%. Regarding short-term risk, FLDM is less volatile compared to PRENW. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs SERA Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, SERA has a market cap of 62.4M. Regarding current trading prices, FLDM is priced at $3.71, while SERA trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas SERA's P/E ratio is -1.81. In terms of profitability, FLDM's ROE is -0.28%, compared to SERA's ROE of -0.51%. Regarding short-term risk, FLDM is less volatile compared to SERA. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs VNRX Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, VNRX has a market cap of 58.4M. Regarding current trading prices, FLDM is priced at $3.71, while VNRX trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas VNRX's P/E ratio is -2.10. In terms of profitability, FLDM's ROE is -0.28%, compared to VNRX's ROE of +1.08%. Regarding short-term risk, FLDM is less volatile compared to VNRX. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs OPGN Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, OPGN has a market cap of 46.3M. Regarding current trading prices, FLDM is priced at $3.71, while OPGN trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas OPGN's P/E ratio is -0.30. In terms of profitability, FLDM's ROE is -0.28%, compared to OPGN's ROE of +1.20%. Regarding short-term risk, FLDM is more volatile compared to OPGN. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs BDSX Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, BDSX has a market cap of 43.3M. Regarding current trading prices, FLDM is priced at $3.71, while BDSX trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas BDSX's P/E ratio is -1.09. In terms of profitability, FLDM's ROE is -0.28%, compared to BDSX's ROE of -1.68%. Regarding short-term risk, FLDM is more volatile compared to BDSX. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs DRIO Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, DRIO has a market cap of 30.9M. Regarding current trading prices, FLDM is priced at $3.71, while DRIO trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas DRIO's P/E ratio is -1.27. In terms of profitability, FLDM's ROE is -0.28%, compared to DRIO's ROE of -0.17%. Regarding short-term risk, FLDM is more volatile compared to DRIO. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs STRRP Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, STRRP has a market cap of 29.9M. Regarding current trading prices, FLDM is priced at $3.71, while STRRP trades at $9.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas STRRP's P/E ratio is -4.66. In terms of profitability, FLDM's ROE is -0.28%, compared to STRRP's ROE of -0.24%. Regarding short-term risk, FLDM is more volatile compared to STRRP. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs AKU Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, FLDM is priced at $3.71, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas AKU's P/E ratio is -0.13. In terms of profitability, FLDM's ROE is -0.28%, compared to AKU's ROE of -5.32%. Regarding short-term risk, FLDM is less volatile compared to AKU. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs ADVB Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, ADVB has a market cap of 20.8M. Regarding current trading prices, FLDM is priced at $3.71, while ADVB trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas ADVB's P/E ratio is -5.99. In terms of profitability, FLDM's ROE is -0.28%, compared to ADVB's ROE of -1.86%. Regarding short-term risk, FLDM is more volatile compared to ADVB. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs CEMI Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, FLDM is priced at $3.71, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas CEMI's P/E ratio is -0.63. In terms of profitability, FLDM's ROE is -0.28%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, FLDM is more volatile compared to CEMI. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs ENZ Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, FLDM is priced at $3.71, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas ENZ's P/E ratio is -2.24. In terms of profitability, FLDM's ROE is -0.28%, compared to ENZ's ROE of -0.39%. Regarding short-term risk, FLDM is less volatile compared to ENZ. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs PRPO Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, PRPO has a market cap of 16.3M. Regarding current trading prices, FLDM is priced at $3.71, while PRPO trades at $10.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas PRPO's P/E ratio is -5.23. In terms of profitability, FLDM's ROE is -0.28%, compared to PRPO's ROE of -0.26%. Regarding short-term risk, FLDM is more volatile compared to PRPO. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs PMD Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, PMD has a market cap of 15.7M. Regarding current trading prices, FLDM is priced at $3.71, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas PMD's P/E ratio is -5.24. In terms of profitability, FLDM's ROE is -0.28%, compared to PMD's ROE of -0.33%. Regarding short-term risk, FLDM is more volatile compared to PMD. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs ME Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, ME has a market cap of 13.3M. Regarding current trading prices, FLDM is priced at $3.71, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas ME's P/E ratio is -0.03. In terms of profitability, FLDM's ROE is -0.28%, compared to ME's ROE of -3.10%. Regarding short-term risk, FLDM is less volatile compared to ME. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs BNGO Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, BNGO has a market cap of 12.4M. Regarding current trading prices, FLDM is priced at $3.71, while BNGO trades at $3.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas BNGO's P/E ratio is -0.07. In terms of profitability, FLDM's ROE is -0.28%, compared to BNGO's ROE of -1.57%. Regarding short-term risk, FLDM is more volatile compared to BNGO. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs TRIB Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, TRIB has a market cap of 12M. Regarding current trading prices, FLDM is priced at $3.71, while TRIB trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas TRIB's P/E ratio is -0.36. In terms of profitability, FLDM's ROE is -0.28%, compared to TRIB's ROE of +0.79%. Regarding short-term risk, FLDM is more volatile compared to TRIB. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs INBS Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, INBS has a market cap of 10.8M. Regarding current trading prices, FLDM is priced at $3.71, while INBS trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas INBS's P/E ratio is -1.18. In terms of profitability, FLDM's ROE is -0.28%, compared to INBS's ROE of -1.72%. Regarding short-term risk, FLDM is less volatile compared to INBS. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs CNTG Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, FLDM is priced at $3.71, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas CNTG's P/E ratio is -0.23. In terms of profitability, FLDM's ROE is -0.28%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, FLDM is less volatile compared to CNTG. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs BIAF Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, BIAF has a market cap of 8.5M. Regarding current trading prices, FLDM is priced at $3.71, while BIAF trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas BIAF's P/E ratio is -0.42. In terms of profitability, FLDM's ROE is -0.28%, compared to BIAF's ROE of -3.68%. Regarding short-term risk, FLDM is less volatile compared to BIAF. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs MYNZ Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, MYNZ has a market cap of 7.7M. Regarding current trading prices, FLDM is priced at $3.71, while MYNZ trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas MYNZ's P/E ratio is -0.09. In terms of profitability, FLDM's ROE is -0.28%, compared to MYNZ's ROE of -22.70%. Regarding short-term risk, FLDM is more volatile compared to MYNZ. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs STRR Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, STRR has a market cap of 7.3M. Regarding current trading prices, FLDM is priced at $3.71, while STRR trades at $2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas STRR's P/E ratio is -0.76. In terms of profitability, FLDM's ROE is -0.28%, compared to STRR's ROE of -0.24%. Regarding short-term risk, FLDM is less volatile compared to STRR. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs BIAFW Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, BIAFW has a market cap of 6.1M. Regarding current trading prices, FLDM is priced at $3.71, while BIAFW trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas BIAFW's P/E ratio is N/A. In terms of profitability, FLDM's ROE is -0.28%, compared to BIAFW's ROE of -3.68%. Regarding short-term risk, FLDM is more volatile compared to BIAFW. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs BGLC Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, BGLC has a market cap of 5.9M. Regarding current trading prices, FLDM is priced at $3.71, while BGLC trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas BGLC's P/E ratio is -2.74. In terms of profitability, FLDM's ROE is -0.28%, compared to BGLC's ROE of -0.24%. Regarding short-term risk, FLDM is more volatile compared to BGLC. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs NVTA Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, FLDM is priced at $3.71, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas NVTA's P/E ratio is -0.00. In terms of profitability, FLDM's ROE is -0.28%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, FLDM is less volatile compared to NVTA. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs LMDXW Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, FLDM is priced at $3.71, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, FLDM's ROE is -0.28%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, FLDM is less volatile compared to LMDXW. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs LMDX Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, FLDM is priced at $3.71, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas LMDX's P/E ratio is -0.01. In terms of profitability, FLDM's ROE is -0.28%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, FLDM is less volatile compared to LMDX. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs CHEK Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, CHEK has a market cap of 4.8M. Regarding current trading prices, FLDM is priced at $3.71, while CHEK trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas CHEK's P/E ratio is -0.38. In terms of profitability, FLDM's ROE is -0.28%, compared to CHEK's ROE of -0.52%. Regarding short-term risk, FLDM is more volatile compared to CHEK. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs TTOO Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, TTOO has a market cap of 4.5M. Regarding current trading prices, FLDM is priced at $3.71, while TTOO trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas TTOO's P/E ratio is -5.33. In terms of profitability, FLDM's ROE is -0.28%, compared to TTOO's ROE of +2.06%. Regarding short-term risk, FLDM is more volatile compared to TTOO. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs DMTK Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, FLDM is priced at $3.71, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas DMTK's P/E ratio is -0.04. In terms of profitability, FLDM's ROE is -0.28%, compared to DMTK's ROE of -0.80%. Regarding short-term risk, FLDM is less volatile compared to DMTK. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs BNR Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, BNR has a market cap of 3.1M. Regarding current trading prices, FLDM is priced at $3.71, while BNR trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas BNR's P/E ratio is -0.62. In terms of profitability, FLDM's ROE is -0.28%, compared to BNR's ROE of -0.53%. Regarding short-term risk, FLDM is less volatile compared to BNR. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs ISPC Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, ISPC has a market cap of 3.1M. Regarding current trading prices, FLDM is priced at $3.71, while ISPC trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas ISPC's P/E ratio is -0.10. In terms of profitability, FLDM's ROE is -0.28%, compared to ISPC's ROE of -2.39%. Regarding short-term risk, FLDM is more volatile compared to ISPC. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs AWH Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, AWH has a market cap of 2.9M. Regarding current trading prices, FLDM is priced at $3.71, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas AWH's P/E ratio is -0.09. In terms of profitability, FLDM's ROE is -0.28%, compared to AWH's ROE of +4.66%. Regarding short-term risk, FLDM is less volatile compared to AWH. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs APDN Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, APDN has a market cap of 2.9M. Regarding current trading prices, FLDM is priced at $3.71, while APDN trades at $5.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas APDN's P/E ratio is N/A. In terms of profitability, FLDM's ROE is -0.28%, compared to APDN's ROE of -2.81%. Regarding short-term risk, FLDM is less volatile compared to APDN. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs NDRA Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, NDRA has a market cap of 2.7M. Regarding current trading prices, FLDM is priced at $3.71, while NDRA trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas NDRA's P/E ratio is 0.01. In terms of profitability, FLDM's ROE is -0.28%, compared to NDRA's ROE of -1.96%. Regarding short-term risk, FLDM is more volatile compared to NDRA. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs SQL Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, FLDM is priced at $3.71, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas SQL's P/E ratio is -0.40. In terms of profitability, FLDM's ROE is -0.28%, compared to SQL's ROE of +10.89%. Regarding short-term risk, FLDM is less volatile compared to SQL. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs HTGM Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, FLDM is priced at $3.71, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas HTGM's P/E ratio is -0.03. In terms of profitability, FLDM's ROE is -0.28%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, FLDM is more volatile compared to HTGM. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs SQLLW Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, SQLLW has a market cap of 871.8K. Regarding current trading prices, FLDM is priced at $3.71, while SQLLW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas SQLLW's P/E ratio is -0.04. In terms of profitability, FLDM's ROE is -0.28%, compared to SQLLW's ROE of -19.68%. Regarding short-term risk, FLDM is more volatile compared to SQLLW. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs BIOC Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, FLDM is priced at $3.71, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas BIOC's P/E ratio is -0.01. In terms of profitability, FLDM's ROE is -0.28%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, FLDM is less volatile compared to BIOC. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs OCDX Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, OCDX has a market cap of 0. Regarding current trading prices, FLDM is priced at $3.71, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas OCDX's P/E ratio is -42.28. In terms of profitability, FLDM's ROE is -0.28%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, FLDM is more volatile compared to OCDX. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.
FLDM vs MEUSW Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, FLDM is priced at $3.71, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas MEUSW's P/E ratio is N/A. In terms of profitability, FLDM's ROE is -0.28%, compared to MEUSW's ROE of -3.10%. Regarding short-term risk, FLDM is less volatile compared to MEUSW. This indicates potentially lower risk in terms of short-term price fluctuations for FLDM.
FLDM vs DHR-PA Comparison
FLDM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, FLDM is priced at $3.71, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, FLDM's ROE is -0.28%, compared to DHR-PA's ROE of +0.07%. Regarding short-term risk, FLDM is more volatile compared to DHR-PA. This indicates potentially higher risk in terms of short-term price fluctuations for FLDM.